Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 3
2004 5
2005 1
2006 3
2007 13
2008 13
2009 12
2010 15
2011 27
2012 27
2013 25
2014 27
2015 23
2016 23
2017 24
2018 25
2019 31
2020 37
2021 49
2022 39
2023 41
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

428 results

Results by year

Filters applied: . Clear all
Page 1
2020 International Society of Hypertension Global Hypertension Practice Guidelines.
Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, Ramirez A, Schlaich M, Stergiou GS, Tomaszewski M, Wainford RD, Williams B, Schutte AE. Unger T, et al. Among authors: schlaich m. Hypertension. 2020 Jun;75(6):1334-1357. doi: 10.1161/HYPERTENSIONAHA.120.15026. Epub 2020 May 6. Hypertension. 2020. PMID: 32370572 Free article. No abstract available.
Hypertension management in patients with cardiovascular comorbidities.
Lauder L, Mahfoud F, Azizi M, Bhatt DL, Ewen S, Kario K, Parati G, Rossignol P, Schlaich MP, Teo KK, Townsend RR, Tsioufis C, Weber MA, Weber T, Böhm M. Lauder L, et al. Among authors: schlaich mp. Eur Heart J. 2023 Jun 20;44(23):2066-2077. doi: 10.1093/eurheartj/ehac395. Eur Heart J. 2023. PMID: 36342266 Review.
Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial.
Schlaich MP, Bellet M, Weber MA, Danaietash P, Bakris GL, Flack JM, Dreier RF, Sassi-Sayadi M, Haskell LP, Narkiewicz K, Wang JG; PRECISION investigators. Schlaich MP, et al. Lancet. 2022 Dec 3;400(10367):1927-1937. doi: 10.1016/S0140-6736(22)02034-7. Epub 2022 Nov 7. Lancet. 2022. PMID: 36356632 Clinical Trial.
2020 International Society of Hypertension global hypertension practice guidelines.
Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, Ramirez A, Schlaich M, Stergiou GS, Tomaszewski M, Wainford RD, Williams B, Schutte AE. Unger T, et al. Among authors: schlaich m. J Hypertens. 2020 Jun;38(6):982-1004. doi: 10.1097/HJH.0000000000002453. J Hypertens. 2020. PMID: 32371787 No abstract available.
Bexagliflozin for type 2 diabetes: an overview of the data.
Azzam O, Carnagarin R, Lugo-Gavidia LM, Nolde J, Matthews VB, Schlaich MP. Azzam O, et al. Among authors: schlaich mp. Expert Opin Pharmacother. 2021 Nov;22(16):2095-2103. doi: 10.1080/14656566.2021.1959915. Epub 2021 Jul 29. Expert Opin Pharmacother. 2021. PMID: 34292100 Review.
International Consensus on Standardized Clinic Blood Pressure Measurement - A Call to Action.
Cheung AK, Whelton PK, Muntner P, Schutte AE, Moran AE, Williams B, Sarafidis P, Chang TI, Daskalopoulou SS, Flack JM, Jennings G, Juraschek SP, Kreutz R, Mancia G, Nesbitt S, Ordunez P, Padwal R, Persu A, Rabi D, Schlaich MP, Stergiou GS, Tobe SW, Tomaszewski M, Williams KA Sr, Mann JFE. Cheung AK, et al. Among authors: schlaich mp. Am J Med. 2023 May;136(5):438-445.e1. doi: 10.1016/j.amjmed.2022.12.015. Epub 2023 Jan 6. Am J Med. 2023. PMID: 36621637 No abstract available.
428 results